HIGHLIGHTS
- who: Egidio Imbalzano et al. from the Department of Clinical and Experimental Medicine, University of Messina, nViale Benedetto XV, n6, Messina, Italy have published the article: Alarmins as a Possible Target of Future Therapies for Atrial Fibrillation, in the Journal: (JOURNAL) of 13/Dec/2022
- what: In the literature review the authors evaluate the role of HMGB1 proteins heat shock proteins and S100 in the pathophysiology of atrial fibrillation offering suggestions for possible new therapeutic strategies.
SUMMARY
Atrial fibrillation (AF) is the most common cardiac arrhythmia in the world, with an . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.